Globus Medical (GMED) PT Lowered to $100 at KeyBanc

June 15, 2026 6:53 AM

KeyBanc lowered its price target on Globus Medical (NYSE: GMED) to $100.00 (from $115.00) while maintaining a Overweight rating.

No results found